KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation-Reference-Cited by-同舟云学术

KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation

Published:2020-11-06 Issue:1 Volume:21 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Lastraioli Elena¹^ORCID,Antonuzzo Lorenzo²,Fantechi Beatrice²,Di Cerbo Luisa²,Di Costanzo Alessandro²,Lavacchi Daniele²,Armenio Miriam¹,Arcangeli Annarosa¹,Castiglione Francesca³,Messerini Luca¹,Di Costanzo Francesco²

Affiliation:

1. Department of Experimental and Clinical Medicine, University of Florence, I-50134 Florence, Italy

2. Medical Oncology Unit, Azienda Ospedaliero‑Universitaria Careggi, I-50134 Florence, Italy

3. Section of Pathological Anatomy, Department of Health Sciences, University of Florence, Azienda Ospedaliero‑Universitaria Careggi, I-50134 Florence, Italy

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients;Heliyon;2023-11

2. Evaluation of RAS Mutational Status in Liquid Biopsy to Monitor Disease Progression in Metastatic Colorectal Cancer Patients;Cells;2023-05-24

3. Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer;Frontiers in Oncology;2022-11-29

4. Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer;Anti-Cancer Drugs;2022-11-15

5. Chemotherapy-induced Reversion of Mutant RAS to Wild-type RAS in Metastatic Colorectal Cancer;Anticancer Research;2022-04-30